FDAnews
www.fdanews.com/articles/159812-stada-widens-biotech-drug-offering-with-filgrastim-license

Stada Widens Biotech Drug Offering With Filgrastim License

October 29, 2013
German generic drugmaker Stada said that it will begin selling a version of Amgen’s cancer drug filgrastim across almost all of the EU.
Reuters